NQ Mobile (NYSE:
NQ) shares reached a new 52-week low of $4.45 after the company announced certain changes to its Board of Directors and provided a status update on its 2013 annual audit.
Regado Biosciences (NASDAQ:
RGDO) shares touched a new 52-week low of $2.90 following the announcement of halt of patient enrollment in
REGULATE-PCI trial. Wedbush downgraded Regado Biosciences from Outperform to Underperform.
MELA Sciences (NASDAQ:
MELA) shares reached a new 52-week low of $0.303 after the company approved a one-for-ten reverse stock split of the common stock.
Globeimmune (NASDAQ:
GBIM) shares tumbled 4.71% to touch a new 52-week low of $10.53. Globeimmune has a 52-week high of $12.14.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
